Syndax Pharmaceuticals (STU:1T3) Other Gross PPE : €0.93 Mil (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Syndax Pharmaceuticals Other Gross PPE?

Syndax Pharmaceuticals's Other Gross PPE for the quarter that ended in Jun. 2024 was €0.93 Mil.

Syndax Pharmaceuticals's quarterly Other Gross PPE declined from Dec. 2023 (€1.59 Mil) to Mar. 2024 (€1.15 Mil) and declined from Mar. 2024 (€1.15 Mil) to Jun. 2024 (€0.93 Mil).

Syndax Pharmaceuticals's annual Other Gross PPE declined from Dec. 2021 (€1.36 Mil) to Dec. 2022 (€1.22 Mil) but then increased from Dec. 2022 (€1.22 Mil) to Dec. 2023 (€1.59 Mil).

Syndax Pharmaceuticals Other Gross PPE Historical Data

The historical data trend for Syndax Pharmaceuticals's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syndax Pharmaceuticals Other Gross PPE Chart

Syndax Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

1.03

0.59

1.36

1.22

1.59

Syndax Pharmaceuticals Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Gross PPE	Get a 7-Day Free Trial															1.83	1.63	1.59	1.15	0.93

Syndax Pharmaceuticals Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Syndax Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syndax Pharmaceuticals Inc (STU:1T3) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

SNDX:USA

Address

35 Gatehouse Drive, Building D, Floor 3, Waltham, MA, USA, 02451

Website

https://www.syndax.com

Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

Syndax Pharmaceuticals Headlines

No Headlines